CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $48 | – | 13,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 755,028 | $1,736,564 | 0.43% |
| Monaco Asset Management SAM | 359,739 | $827,400 | 0.24% |
| Slate Path Capital LP | 2,402,455 | $5,525,647 | 0.15% |
| SANDERS MORRIS HARRIS LLC | 346,212 | $713,426 | 0.15% |
| ADVISORY RESEARCH INC | 257,225 | $591,618 | 0.08% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,100,550 | 0.07% |
| Annandale Capital, LLC | 65,000 | $150 | 0.04% |
| Good Life Advisors, LLC | 112,000 | $257,600 | 0.03% |
| CARLSON CAPITAL L P | 135,000 | $310,500 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 57,888 | $133,142 | 0.02% |